Workflow
四赴进博!瑞士爱尔康为银发族守住清晰视界
Guo Ji Jin Rong Bao·2025-11-06 13:45

Core Insights - Alcon has transitioned from "innovation experience docking" to "innovation ecosystem co-construction" in China, aiming to accelerate the localization of innovative results and expand professional education resources for high-quality development in the eye health industry [1][4]. Group 1: Market Position and Strategy - China is one of Alcon's fastest-growing and strategically significant markets, with the company witnessing and participating in the high-quality development of the eye health industry over the past 30 years [4]. - Alcon plans to continue investing in local clinical needs to feed back into the global innovation system, contributing to the next phase of development in China's eye health sector [4][10]. Group 2: Demographic Trends - China has entered a deep aging phase, with 15.6% of the population aged 65 and above, leading to increasingly diverse and customized eye health needs among the elderly [4]. - The prevalence of eye diseases such as cataracts and glaucoma is rising among the elderly, who now demand higher visual quality beyond just "seeing" to "seeing clearly and comfortably" [4]. Group 3: Product Innovations - At the China International Import Expo, Alcon showcased a range of innovative products, including the new material artificial intraocular lens (ATIOL) and products supporting glaucoma and cataract treatment [5][6]. - The Clareon PanOptix Pro series offers enhanced visual quality and meets various vision needs, while the Hydrus glaucoma stent provides a minimally invasive solution with lower complication risks compared to traditional surgeries [6][9]. - Alcon's vision care division introduced a family of contact lenses utilizing patented layered hydration technology, enhancing comfort for astigmatism patients [9]. Group 4: Collaborations and Local Production - Alcon signed collaborations with institutions like Sun Yat-sen University Eye Center and announced plans for local production of Wavelight® excimer laser surgery equipment in China, pending regulatory approval [10]. - The company has established professional education centers nationwide and innovation experience centers in Beijing and Shanghai to deepen its commitment to the Chinese market [10].